Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 10B | 10.2B | 10.0B | 9.5B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 3.7B | 3.7B | 3.5B | 3.3B |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 1.7B | 1.5B | 2.2B | 651M |
Tax provision | 325M | 366M | 441M | 54M |
Net income | 1.4B | 1.1B | 1.8B | 597M |
Basic EPS | 3.5 | 2.7 | 4.4 | 1.4 |
Diluted EPS | 3.5 | 2.7 | 4.4 | 1.4 |
Basic average shares | 383.1M | 382.4M | 383M | 383.1M |
Diluted average shares | 384M | 383.4M | 383.7M | 383.9M |
EBITDA | — | — | — | — |
Net income from continuing op. | 1.4B | 1.1B | 1.8B | 597M |
Minority interests | — | — | — | — |
Preferred stock dividends | 22M | 17M | 28M | 9M |